Clinical trial
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
NCT07179692
Study timeline
Study start (actual)2025-09-12Date precision: day
Registry last updated2025-10-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerverified · MONDO: lung cancer
Gastric Cancerverified · MONDO: gastric cancer
Colon Cancerverified · MONDO: malignant colon neoplasm
Rectal Cancerverified · MONDO: rectal cancer
Esophageal Cancerverified · MONDO: esophageal cancer
Interventions
CEA-targeted CAR-T cellsBIOLOGICAL
CEA-targeted CAR-T cellsBIOLOGICAL
CEA-targeted CAR-T cellsBIOLOGICAL
Sponsors & collaborators
Chongqing Precision Biotech Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07179692 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.